Page last updated: 2024-08-16

zonisamide and toloxatone

zonisamide has been researched along with toloxatone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F	1
Efimova, J; Ivanovskii, S; Petzer, A; Petzer, JP; Shetnev, A; Shlenev, R; Tarasov, A	1

Other Studies

2 other study(ies) available for zonisamide and toloxatone

Article	Year
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors. Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23 Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship	2009
1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B. Bioorganic & medicinal chemistry letters, 2019, 11-01, Volume: 29, Issue:21 Topics: Amino Acid Sequence; Antidepressive Agents; Benzenesulfonamides; Benzoates; Binding Sites; Drug Evaluation, Preclinical; Humans; Isomerism; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Zonisamide	2019

Article

Year

Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.

Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23

Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship

2009

1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.

Bioorganic & medicinal chemistry letters, 2019, 11-01, Volume: 29, Issue:21

Topics: Amino Acid Sequence; Antidepressive Agents; Benzenesulfonamides; Benzoates; Binding Sites; Drug Evaluation, Preclinical; Humans; Isomerism; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Zonisamide

2019